Rhys brings more than 15 years’ experience in commercialisation of life science research in both academia and industry around the world, including previous roles with Origen Therapeutics and MerseyBIO, and he now advises a number of UK and international companies. He is a serving executive director of 2Bio Ltd., a UK-based technology commercialisation consultancy that he co-founded in 2007. 2Bio evaluates and protects intellectual property (IP) on behalf of international clients and has developed a significant UK healthcare practice, working with major hospitals to transform their diverse portfolios of IP into valuable new business. Rhys is a graduate from the University of Edinburgh.
